Company Search:
Advanced Search
Sponsored Links
Eps Corp Company Snapshot
Eps Corp operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Eps Corp with three other miscellaneous service companies in Asia: Takara Bio Inc (2018 sales of 32.31 billion Japanese Yen [US$288.22 million] of which 92% was Bio support), Chabiotech Co Ltd of South Korea (488.60 billion Korean Won [US$431.43 million] of which 90% was health care), and Genscript Biotech Corp which is based in Hong Kong (1.81 billion Hong Kong Dollars [US$230.82 million] of which 61% was Bio-Science services and products).

Sales Analysis. Eps Corp reported sales of ¥65.77 billion (US$586.66 million) for the fiscal year ending September of 2018. This represents an increase of 8.7% versus 2017, when the company's sales were ¥60.48 billion. Sales at Eps Corp have increased during each of the previous five years (and since 2013, sales have increased a total of 75%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Eps Corp
  Stock Performance Chart for Eps Corp
  Stock Data: Recent Stock Performance:
  Current Price (4/19/2019): 1,919.00
(Figures in Japanese Yen)
1 Week -0.1%   13 Weeks -0.2%  
4 Weeks 13.8%   52 Weeks -13.9%  
Eps Corp Key Data:
  Ticker: 4282 Country: Japan
  Exchanges: OTH Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 65,769,000,000
(Year Ending Jan 2019).
Employees: 5,695
  Currency: Japanese Yen Market Cap: 87,042,454,884
  Fiscal Yr Ends: September Shares Outstanding: 45,358,236
  Share Type: Common Closely Held Shares: 20,221,627
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.